We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

76 hedge funds and large institutions have $95.4M invested in Minerva Neurosciences in 2020 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 30 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.17% more ownership

Funds ownership: 8.85% → 9.03% (+0.17%)

5% less funds holding

Funds holding: 80 → 76 (-4)

7% less capital invested

Capital invested by funds: $103M → $95.4M (-$7.4M)

29% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 14

38% less call options, than puts

Call options by funds: $552K | Put options by funds: $891K

43% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 30

Holders
76
Holders Change
-4
Holders Change %
-5%
% of All Funds
1.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
17
Reduced
30
Closed
14
Calls
$552K
Puts
$891K
Net Calls
-$339K
Net Calls Change
+$1.95M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.94M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$2.67M
3
OM
Opaleye Management
Massachusetts
+$2.59M
4
FM
Frazier Management
Washington
+$1.86M
5
Goldman Sachs
Goldman Sachs
New York
+$1.42M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.48M
2
CAM
Cormorant Asset Management
Massachusetts
-$924K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$915K
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$708K
5
Jane Street
Jane Street
New York
-$696K
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$30.6M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$12.9M +$2.94M +108,785 +27%
BlackRock
3
BlackRock
New York
$6.68M -$373K -13,792 -5%
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$5.42M +$2.67M +98,935 +87%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$3.75M -$407K -15,040 -9%
Goldman Sachs
6
Goldman Sachs
New York
$3.73M +$1.42M +52,540 +56%
OM
7
Opaleye Management
Massachusetts
$2.44M +$2.59M +95,925 New
AG
8
Artal Group
Luxembourg
$2.42M -$135K -5,000 -5%
Renaissance Technologies
9
Renaissance Technologies
New York
$2.06M -$236K -8,725 -10%
State Street
10
State Street
Massachusetts
$1.94M +$181K +6,682 +10%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$1.93M +$209K +7,733 +11%
FM
12
Frazier Management
Washington
$1.75M +$1.86M +68,750 New
N
13
Nuveen
North Carolina
$1.68M -$449K -16,607 -52%
AC
14
Armistice Capital
New York
$1.59M +$676K +25,000 +67%
Fidelity Investments
15
Fidelity Investments
Massachusetts
$1.45M -$3.48M -128,756 -69%
NLVP
16
New Leaf Venture Partners
New York
$1.43M – – –
Jacobs Levy Equity Management
17
Jacobs Levy Equity Management
New Jersey
$1.33M +$544K +20,111 +62%
Northern Trust
18
Northern Trust
Illinois
$1.21M +$152K +5,628 +13%
Two Sigma Advisers
19
Two Sigma Advisers
New York
$1.07M +$968K +35,800 +563%
CAM
20
Cormorant Asset Management
Massachusetts
$759K -$924K -34,168 -53%
Russell Investments Group
21
Russell Investments Group
United Kingdom
$749K +$110K +4,069 +16%
SEI Investments
22
SEI Investments
Pennsylvania
$742K +$273K +10,099 +53%
Arrowstreet Capital
23
Arrowstreet Capital
Massachusetts
$666K -$708K -26,177 -50%
AllianceBernstein
24
AllianceBernstein
Tennessee
$662K -$116K -4,288 -14%
Two Sigma Investments
25
Two Sigma Investments
New York
$636K +$675K +24,984 New
1
2 3 4

NERV Hedge Fund Activity: Q3 2020 in Review

76 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q3 2020, worth a combined $95.4M — down 7.2% from $103M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of NERV and 10 opened new positions — a net loss of 4 holders — while 30 trimmed existing stakes and 17 added.

The largest buyer was Vanguard Group, adding an estimated $2.94M. The largest seller was Fidelity Investments, cutting an estimated $3.48M.

  • 76 institutional investors held Minerva Neurosciences (NERV) as of Q3 2020, down from 80 in Q2 2020.
  • Funds reported $95.4M of Minerva Neurosciences stock for Q3 2020, down 7.2% quarter-over-quarter.
  • 10 funds opened new Minerva Neurosciences positions in Q3 2020 and 14 closed out, a net change of -4 holders.
  • The largest Minerva Neurosciences buyer in Q3 2020 was Vanguard Group, an estimated $2.94M added.
  • The largest Minerva Neurosciences seller in Q3 2020 was Fidelity Investments, an estimated $3.48M sold.

Based on aggregated 13F filings for Q3 2020.